Breast reconstructive surgery: Providing options for women Hospital News, Canada - For many women who face the prospect of losing their breast(s) due to cancer, breast reconstructive surgery is an option. The goal of breast reconstruction ...
Radioactive 'Seed' Rx Helps Women With Implants Fight Breast Cancer U.S. News & World Report, DC - 5 minutes ago ... with a larger tumor," she said, because the radiation oncologist would need to treat more of the breast, thus increasing the risk of capsular contracture.
'Butcher' surgeon free to practise The Press Association - Mr Gwynn remains suspended from breast surgery until the GMC lifts the restriction at a hearing in February next year. The panel will then consider whether ...
Source: Google News
Recent News and Articles on the Keywords: cancer + preventive + breast Related to the article below (Last Update: 8/7/2008)
Kenya lacks guidlines to manage cervical cancer Africa Science News Service, Kenya - Aug 5, 2008 The limited data available in Kenya places it as the most common cancer among Women followed by the Breast Cancer. The international agency for Research on ...
Crosstex to launch women's cancer initiative RDH, OK - When dental professionals purchase Crosstex Pink products, a portion of the proceeds will go toward funding breast and reproductive cancer research at ...
Health Front and Center Publishers Weekly, NY - Aug 4, 2008 Fireside is launching its 10 Best Questions series with The 10 Best Questions for Surviving Breast Cancer by Dede Bonner, on sale in October. ...
Overview of the Main Outcomes in Breast Cancer Prevention Trials. - J Cuzick, T Powles, U Veronesi, J Forbes, R … - Obstetrical & Gynecological Survey, 2003 - obgynsurvey.com ... modulator (SERM) for both preventive and adjuvant ... for its effectiveness in breast cancer management, although ... assess its effect in the prevention and treatment ...
Recent Trends in US Breast Cancer Incidence, Survival, and Mortality Rates - KC Chu, RE Tarone, LG Kessler, LAG Ries, BF Hankey … - jnci, 1996 - jnci.oxfordjournals.org ... of the Evidence for the US Preventive Services Task ... JC Weeks Life Expectancy Gains
From CancerPrevention Strategies for Women With BreastCancer and BRCA1 ...
The use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women. - GA Colditz, SE Hankinson, DJ Hunter, WC Willet, … - Obstetrical & Gynecological Survey, 1995 - obgynsurvey.com ... European Journal of CancerPrevention. ... Postmenopausal Hormone Replacement Therapy
for the Primary Prevention of Chronic ... US Preventive Services Task Force. ...
Preventive surgery reduces the risk of BRCA-associated breast and ovarian cancers
A multicenter study is the first to suggest that the prophylactic removal of the ovaries and fallopian tubes may provide a different benefit for women who carry a genetic mutation in the BRCA2 gene than for those who have a BRCA1 genetic mutation.
The results of the study also provide the strongest evidence to date that this surgery significantly reduces the overall risk of BRCA-associated breast and ovarian cancers.
The study followed 886 women over the age of 30 who carry the BRCA1 or BRCA2 genetic mutation. Of this group, 561 opted to have their ovaries and fallopian tubes surgically removed - a procedure called risk-reducing salpingo-oophorectomy - while 325 chose to participate in ovarian surveillance. The women were followed for 40 months via questionnaire or medical review.
The results showed that overall the prophylactic surgery reduced the incidence of ovarian and related cancers by 89 percent and decreased breast cancer incidence by 47 percent.
When broken down further, the results have indicated that none of the women carrying the BRCA2 mutation who had the surgery developed ovarian cancer, while women carrying the BRCA1 mutation who had the surgery decreased their risk of developing ovarian or related cancers by 87 percent.
The study showed that women with BRCA2 mutations also reduced their risk of developing breast cancer by 72 percent, while those with BRCA1 mutations reduced their risk of breast cancer by 39 percent.
Why the results of the procedure differ in BRCA1 carriers and BRCA2 carriers is "a question that we are currently exploring and hope to answer in future studies," said the study's lead author Noah Kauff, at Memorial Sloan-Kettering Cancer Center ( MSKCC ).
Source: Memorial Sloan-Kettering Cancer Center, 2006
